Kristen Veraldi is a Respiratory physician affiliated with University of Pittsburgh. OpenAlex indexes 30 publications with 1,066 citations (h-index 15); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: University of Pittsburgh
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Sponsor: University of Pittsburgh
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: University of Pittsburgh
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
66.2%Folate Analog Metabolic Inhibitor33.8%Methotrexate100%Part D<11 patientsKinase inhibitor32.5%Ofev100%Part D<11 patientsRespiratory
16.9%Corticosteroid16.9%Breo Ellipta100%Part D<11 patientsMetabolism & gastrointestinal
16.9%Corticosteroid16.9%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2013 per NIH RePORTER. The latest:
- IGFBP-5 and Hsp70 in Extracellular Matrix Homeostasis and Fibrosis
University of Pittsburgh at Pittsburgh
FY2013$124,869K08HL094764 - IGFBP-5 and Hsp70 in Extracellular Matrix Homeostasis and Fibrosis
University of Pittsburgh at Pittsburgh
FY2012$124,869K08HL094764 - IGFBP-5 and Hsp70 in Extracellular Matrix Homeostasis and Fibrosis
University of Pittsburgh at Pittsburgh
FY2011$124,869K08HL094764
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Creation of a virtual cancer care network for remote oncology treatment.
Journal of Clinical Oncology
2019 - Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Norman Wolmark, MD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Udai Kammula, MD
University of Pittsburgh
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”